STOCK TITAN

AtlasClear grants director 626,881 stock options

The October award vests in three equal annual installments starting October 1, 2027, at an exercise price of $0.201 per share.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

AtlasClear Holdings, Inc. (ATCH) director Thomas Jon Hammond was granted stock options to acquire 35,000, 731,030 and 626,881 common shares. The two awards dated July 14, 2026, have exercise prices of $0.18 per share and expire January 26, 2030, and June 30, 2031, respectively. The October 1, 2026, award has a $0.201 exercise price, expires October 1, 2033, and vests in three equal annual installments beginning October 1, 2027.

Insider Hammond Thomas Jon
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) F1 626,881 $0.00 $0.00
Grant/Award Stock Option (right to buy) 35,000 $0.00 $0.00
Grant/Award Stock Option (right to buy) 731,030 $0.00 $0.00
Holdings After Transaction: Stock Option (right to buy) — 1,392,911 contracts (Direct)
Footnotes (1)
  1. F1. The option vests in three equal annual installments beginning October 1, 2027.
Stock options 35,000 options Granted July 14, 2026; expire January 26, 2030
Exercise price $0.18 per share Award dated July 14, 2026; expires January 26, 2030
Stock options 731,030 options Granted July 14, 2026; expire June 30, 2031
Exercise price $0.18 per share Award dated July 14, 2026; expires June 30, 2031
Stock options 626,881 options Granted October 1, 2026; expire October 1, 2033
Exercise price $0.201 per share Award dated October 1, 2026; expires October 1, 2033
Stock Option (right to buy) financial
"Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vests in three equal annual installments financial
"The option vests in three equal annual installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock options did ATCH director Thomas Jon Hammond receive?

Thomas Jon Hammond received options to acquire 35,000 and 731,030 common shares on July 14, 2026, and 626,881 common shares on October 1, 2026. The July awards have an exercise price of $0.18 per share; the October award has an exercise price of $0.201 per share.

When do Thomas Jon Hammond's ATCH stock options vest?

The award of 626,881 options dated October 1, 2026, vests in three equal annual installments beginning October 1, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hammond Thomas Jon

(Last)(First)(Middle)
C/O ATLASCLEAR HOLDINGS, INC.
4350 WEST CYPRESS STREET, SUITE 270

(Street)
TAMPA FLORIDA 33607

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AtlasClear Holdings, Inc. [ ATCH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$0.20110/01/2026A626,881 (1)10/01/2033Common Stock626,881$0626,881D
Stock Option (right to buy)$0.1807/14/2026A35,00007/14/202601/26/2030Common Stock35,000$035,000D
Stock Option (right to buy)$0.1807/14/2026A731,03007/14/202606/30/2031Common Stock731,030$0731,030D
Explanation of Responses:
1. The option vests in three equal annual installments beginning October 1, 2027.
/s/ Jason Simon, Attorney-in-Fact10/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading